Applying The Asco And Esmo Value Frameworks To Nasopharyngeal Cancer Treatments: Is Adding Induction Chemotherapy Or Adjuvant Chemotherapy To Concurrent Chemoradiotherapy Worthwhile?

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 0|浏览9
暂无评分
摘要
67Background: To determine and compare the incremental clinical benefit (ICB) and costs of induction chemotherapy (IC) when added to concurrent chemoradiotherapy (CCRT), concurrent chemotherapy (CC...
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要